Covid-19 Update

Christopher Chope Excerpts
Friday 26th November 2021

(2 years, 12 months ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Sajid Javid Portrait Sajid Javid
- View Speech - Hansard - - - Excerpts

I want to ensure that all the support that is needed for our vaccination programme is there, across England. The hon. Lady rightly asked what we were doing to reach out to those who, for whatever reason, have so far been a bit hesitant. We have been working actively for months with many community leaders. We have added many more venues and ways in which to receive the vaccine, so access has been improved. Significant work is also being done on communications and ensuring that the right messages are there, and that people, including clinicians, are available to answer questions. However, the hon. Lady was right to point to the importance of this issue, and I am pleased to hear that she will be getting boosted this weekend.

Christopher Chope Portrait Sir Christopher Chope (Christchurch) (Con)
- View Speech - Hansard - -

Ivermectin has shown promising results as a potential treatment for covid-19 in places including South Africa. More than five months ago it was added to the Oxford University trial, which is called PRINCIPLE. When will the results of that trial be available, and what are the Government doing to expedite the process? Ivermectin may not be a magic bullet, but on the other hand, it may be.

Sajid Javid Portrait Sajid Javid
- View Speech - Hansard - - - Excerpts

My hon. Friend has made an important point. One reason for the difference between dealing with this pandemic today and dealing with it even a year ago is that we already have more treatments, and my hon. Friend has just mentioned another potential new treatment. I am afraid that I cannot give him any exact date for when we think the trials will be over, but I am pleased that they are taking place. He is right to point to the potential of that treatment, but I can reassure him that whether the UK’s engagement is with ivermectin or with other potential new treatments, it could not be more engaged.